subject: Gastroesophageal Reflux Disease - Drug Pipeline Analysis And Market Forecasts To 2016 [print this page] Gastroesophageal Reflux Disease - Drug Pipeline Analysis and Market Forecasts to 2016
Summary
The industry analysis specialists new report, Gastroesophageal Reflux Disease (GERD) Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global gastroesophageal reflux disease market. The report identifies the key trends shaping and driving the global gastroesophageal reflux disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global gastroesophageal reflux disease sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by team of industry experts.
Scope
The report provides information on the key driver and challenges of the global GERD market. Its scope includes:
- Annualized global GERD market revenues data from 2000 to 2009, forecast forward for 7 years to 2016.
- Key geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action include H+/K+ ATPase Inhibitor, H2 antagonist, 5-HT4 receptor agonist, GABA-B receptor Agonist and mGluR5 antagonist.
- Analysis of the current and future market competition in the global GERD market. Key market players covered are AstraZeneca, Addex Pharmaceuticals, XenoPort and Vecta.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with GERD.
